SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Munch-a-Biotech Today
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LLCF who wrote (513)7/29/1999 1:44:00 PM
From: RWReeves  Read Replies (1) of 3158
 
For a biotech exec, it can be lot more palatable to expense as you go rather than have to write off a "whopper" when it proves to be a DP (dead player). Many companies have built a lot of plant- cleanrooms, fermentors, fill lines and the like for product lines that didn't work. That's a lot of capitalized expense on risk and nobody wants to be the poor SOB that has to write it off. Expense as you go is pretty conservative- and I think encourages management to spend wisely rather than just capitalize the whole mess for somebody else.

RR
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News